Health Corner
Does a high tumor marker level mean I have cancer?
A tumor marker is not a “cancer diagnosis certificate.” It refers to specific proteins or substances found in the blood or body fluids that often appear elevated in cancer patients. These markers help doctors suspect, monitor, or track the progression of cancer.
What does a high value mean?
These markers are actually molecules that normal cells also produce, but cancer cells may release them in greater quantities or in abnormal forms. When the value rises above the normal range, it acts like a red flag—signaling that further investigation may be needed.
If your tumor marker level is high, don’t panic—several non-cancerous conditions can cause mild to moderate increases, such as:
-
Inflammation (hepatitis, gastritis, pneumonia)
-
Benign growths (liver cirrhosis, uterine fibroids, prostate enlargement)
-
Pregnancy
-
Smoking
On the other hand, some early-stage cancers or certain tumor types may not cause tumor marker elevation. For example, many patients with early breast or ovarian cancer still have normal CA125 or CA15-3 readings.
What can tumor markers reflect?
Tumor markers can serve multiple purposes beyond aiding diagnosis:
-
Diagnostic aid: Elevated values suggest possible malignancy; combined with imaging, they improve accuracy (e.g., high AFP may indicate liver cancer).
-
Cancer staging and metastasis risk: Higher concentrations often correlate with tumor burden, which may indicate advanced disease or metastasis risk.
-
Treatment monitoring: A decreasing marker value indicates treatment effectiveness—for instance, a 50% drop in CEA suggests successful chemotherapy.
-
Predicting drug response: Genetic markers (like EGFR mutations) can anticipate targeted therapy effectiveness; high PD-L1 levels suggest suitability for immunotherapy.
-
Early screening: Certain markers (like PSA for prostate cancer) help screen high-risk groups, though sensitivity is limited and should not be used alone.
Which tumor markers should I check?
| Marker | Common related cancers |
| AFP (Alpha-fetoprotein) | Liver cancer, testicular cancer, ovarian germ cell tumors |
| CEA (Carcinoembryonic antigen) | Colorectal, rectal, gastric, lung, and breast cancers |
| CA125 | Ovarian, endometrial, and breast cancers |
| CA15-3 / CA27.29 | Breast cancer (especially metastatic) |
| CA19-9 | Pancreatic, biliary tract, colorectal, gastric cancers |
| PSA (Prostate-specific antigen) | Prostate cancer |
| CYFRA 21-1 / NSE | Lung cancer (especially squamous cell and small cell types) |
| SCC-Ag (Squamous cell carcinoma antigen) | Cervical, head and neck, esophageal, and squamous lung cancers |
Each cancer type has its corresponding markers, but it’s important to remember that tumor markers are only supplementary tools.
They cannot confirm or rule out cancer by themselves.
Doctors typically rely on imaging (CT, MRI, ultrasound) and tissue biopsy (pathology) for definitive diagnosis.
Even if your marker levels are normal, it’s still essential to undergo regular screenings, such as colonoscopy, mammogram, and Pap smear, to help with early cancer prevention.
